Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
CNC Stock Forecast 2026-2027
$63.89
Current Price
$32.89B
Market Cap
Buy 7
Hold 13
Sell 1
Wall St Analyst Ratings
Distance to CNC Price Targets
+25.2%
To High Target of $80.00
+7.2%
To Median Target of $68.50
-37.4%
To Low Target of $40.00
CNC Price Momentum
-5.1%
1 Week Change
+5.4%
1 Month Change
+119.3%
1 Year Change
+55.3%
Year-to-Date Change
-7.9%
From 52W High of $69.36
+154.7%
From 52W Low of $25.08
📊 TOP ANALYST CALLS
Did CNC Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Centene is one of their latest high-conviction picks.
Latest CNC Stock Price Targets & Analyst Predictions
Based on our analysis of 6 Wall Street analysts, CNC has a neutral consensus with a median price target of $68.50 (ranging from $40.00 to $80.00). The overall analyst rating is Buy (7.0/10). Currently trading at $63.89, the median forecast implies a 7.2% upside. This outlook is supported by 7 Buy, 13 Hold, and 1 Sell ratings.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
CNC Analyst Ratings
7
Buy
13
Hold
1
Sell
CNC Price Target Range
Low
$40.00
Average
$68.50
High
$80.00
Current: $63.89
Latest CNC Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for CNC.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Jul 14, 2026 | Truist Securities | David Macdonald | Buy | Maintains | $78.00 |
| Jul 13, 2026 | Wells Fargo | Stephen Baxter | Equal-Weight | Maintains | $69.00 |
| Jul 9, 2026 | RBC Capital | Ben Hendrix | Sector Perform | Maintains | $71.00 |
| Jul 7, 2026 | Cantor Fitzgerald | Sarah James | Overweight | Maintains | $75.00 |
| Jun 23, 2026 | RBC Capital | Sector Perform | Initiates | $N/A | |
| Jun 8, 2026 | Mizuho | Neutral | Maintains | $N/A | |
| Jun 8, 2026 | JP Morgan | Neutral | Maintains | $N/A | |
| Jun 4, 2026 | B of A Securities | Buy | Maintains | $N/A | |
| Jun 4, 2026 | Morgan Stanley | Equal-Weight | Maintains | $N/A | |
| Jun 1, 2026 | Truist Securities | Buy | Maintains | $N/A | |
| May 26, 2026 | Barclays | Overweight | Maintains | $N/A | |
| May 22, 2026 | UBS | Neutral | Maintains | $N/A | |
| May 21, 2026 | B of A Securities | Buy | Maintains | $N/A | |
| May 20, 2026 | Mizuho | Neutral | Maintains | $N/A | |
| May 20, 2026 | Deutsche Bank | Buy | Upgrade | $N/A | |
| May 4, 2026 | TD Cowen | Hold | Maintains | $N/A | |
| May 1, 2026 | Wells Fargo | Equal-Weight | Maintains | $N/A | |
| Apr 29, 2026 | UBS | Neutral | Maintains | $N/A | |
| Apr 29, 2026 | Oppenheimer | Outperform | Maintains | $N/A | |
| Apr 29, 2026 | Cantor Fitzgerald | Overweight | Upgrade | $N/A |
Centene Corporation (CNC) Competitors
The following stocks are similar to Centene based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Centene Corporation (CNC) Financial Data
Centene Corporation has a market capitalization of $32.89B with a P/E ratio of 8.1x. The company generates $178.33B in trailing twelve-month revenue with a -3.6% profit margin.
Revenue growth is +5.1% quarter-over-quarter, while maintaining an operating margin of +5.1% and return on equity of -26.0%.
Valuation Metrics
Market Cap
$32.89B
Enterprise Value
$26.45B
P/E Ratio
8.1x
PEG Ratio
0.4x
Price/Sales
0.2x
Growth & Margins
Revenue Growth (YoY)
+5.1%
Gross Margin
+11.1%
Operating Margin
+5.1%
Net Margin
-3.6%
EPS Growth
+17.5%
Financial Health
Cash/Price Ratio
+75.3%
Current Ratio
1.1x
Debt/Equity
76.0x
ROE
-26.0%
ROA
+1.2%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Centene Corporation (CNC) Business Model
About Centene Corporation
What They Do
Leading managed healthcare organization for government programs.
Business Model
The company generates revenue primarily through its various government-sponsored health programs, including Medicaid and Medicare. It offers a wide range of healthcare services, such as health insurance products and specialized services, allowing it to cater to both underserved populations and commercial clients.
Additional Information
Founded in 1984 and headquartered in St. Louis, Missouri, the company serves millions of members and focuses on coordinated care delivery and cost management. Its diversified segments also include pharmacy operations, behavioral health, and services for military families, enhancing its role in the U.S. healthcare system.
Company Information
Sector
Healthcare
Industry
Healthcare Plans
Employees
61,000
CEO
Ms. Sarah M. London
Country
United States
IPO Year
2001
Website
www.centene.comCentene Corporation (CNC) Latest News & Analysis
Featured Analysis
Powered by
Zacks Investment Research
Top Stock Reports for Chevron, TotalEnergies & Robinhood
Chevron's long-term growth drivers face regulatory, geopolitical and valuation hurdles, prompting a cautious stance despite solid operational strengths.
Jul 14, 2026
By Mark Vickery
Research Daily
Centene Stock Soars 66% YTD: Should Investors Chase the Rally?
CNC stock's 66% rally reflects improving margins, stronger cash flow and renewed earnings growth, but can the turnaround keep gaining momentum?
Jul 14, 2026
By Kaibalya Pravo Dey
Analyst Blog
Centene's Illinois Medicaid Renewal: A Win for Long-Term Growth?
Centene secures a four-year Illinois Medicaid contract renewal, preserving a key membership base and reinforcing long-term revenue stability.
Jul 10, 2026
By Piyali Saha Sikdar
Analyst Blog
Latest News
Quick Summary
Centene Corporation (CNC) stock has risen 66% in 2026, outperforming the healthcare industry's 28.5% gain, marking a significant recovery for the company.
Why It Matters
Centene's 66% stock surge outpacing industry growth signals strong operational recovery and investor confidence, potentially attracting further investment and impacting market valuations.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
Centene Corporation (NYSE: CNC) will release its Q2 2026 financial results on July 28, 2026, at 6:00 a.m. ET, followed by a conference call at 8:30 a.m. ET.
Why It Matters
Centene's upcoming earnings release and conference call could impact stock performance, providing insights into financial health and operational strategies, key for investment decisions.
Source: PRNewsWire
Market Sentiment:
Neutral
Quick Summary
Centene has renewed its four-year Illinois Medicaid contract, ensuring continued membership and enhancing long-term revenue stability.
Why It Matters
Centene's contract renewal ensures steady revenue and solidifies its market position, enhancing investor confidence in its growth and profitability outlook.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
Centene's Illinois subsidiary, Meridian Health Plan, has been awarded a four-year contract to continue services for the HealthChoice Illinois Medicaid program, effective January 1, 2027.
Why It Matters
Centene's renewal of the Medicaid contract ensures stable revenue and growth potential, positively impacting stock performance and investor confidence in its long-term strategy.
Source: PRNewsWire
Market Sentiment:
Neutral
Quick Summary
Centene Corporation is focusing on executing initiatives to manage medical costs, modernize processes, and enhance payment integrity for margin recovery.
Why It Matters
Centene's focus on managing medical costs and improving processes signals potential margin improvement, which could enhance profitability and attract investor interest.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
CNC is enhancing its AI-based fraud prevention and payment integrity systems to improve Medicaid margins and support long-term earnings growth.
Why It Matters
CNC's AI-driven initiatives enhance Medicaid margins and cost controls, signaling potential for improved profitability and sustainable earnings growth, positively impacting investor confidence.
Source: Zacks Investment Research
Market Sentiment:
Neutral
Frequently Asked Questions About CNC Stock
What is Centene Corporation's (CNC) stock forecast for 2027?
Based on our analysis of 6 Wall Street analysts, Centene Corporation (CNC) has a median price target of $68.50. The highest price target is $80.00 and the lowest is $40.00.
Is CNC stock a good investment in 2027?
According to current analyst ratings, CNC has 7 Buy ratings, 13 Hold ratings, and 1 Sell ratings. The stock is currently trading at $63.89. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for CNC stock?
Wall Street analysts predict CNC stock could reach $68.50 in the next 12 months. This represents a 7.2% increase from the current price of $63.89. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Centene Corporation's business model?
The company generates revenue primarily through its various government-sponsored health programs, including Medicaid and Medicare. It offers a wide range of healthcare services, such as health insurance products and specialized services, allowing it to cater to both underserved populations and commercial clients.
What is the highest forecasted price for CNC Centene Corporation?
Price targets from Wall Street analysts for CNC are not currently available. The stock is trading at $63.89.
What is the lowest forecasted price for CNC Centene Corporation?
The lowest price target for CNC is $40.00 from at , which represents a -37.4% decrease from the current price of $63.89.
What is the overall CNC consensus from analysts for Centene Corporation?
The overall analyst consensus for CNC is neutral. Out of 6 Wall Street analysts, 7 rate it as Buy, 13 as Hold, and 1 as Sell, with a median price target of $68.50.
How accurate are CNC stock price projections?
Stock price projections, including those for Centene Corporation, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: July 17, 2026 2:20 AM UTC